KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $46,000 | -74.0% | 12,200 | -71.7% | 0.00% | – |
| Q1 2018 | $177,000 | +205.2% | 43,072 | +247.4% | 0.00% | – |
| Q4 2017 | $58,000 | -58.9% | 12,400 | -45.7% | 0.00% | -100.0% |
| Q1 2017 | $141,000 | -6.6% | 22,848 | -19.9% | 0.00% | 0.0% |
| Q3 2016 | $151,000 | -50.2% | 28,511 | -37.7% | 0.00% | 0.0% |
| Q2 2016 | $303,000 | -49.9% | 45,749 | -64.7% | 0.00% | -66.7% |
| Q1 2016 | $605,000 | +40.7% | 129,645 | +52.1% | 0.00% | 0.0% |
| Q4 2015 | $430,000 | +36.9% | 85,222 | -4.5% | 0.00% | +50.0% |
| Q3 2015 | $314,000 | +35.3% | 89,276 | +283.9% | 0.00% | 0.0% |
| Q2 2015 | $232,000 | +69.3% | 23,252 | +115.3% | 0.00% | +100.0% |
| Q1 2015 | $137,000 | -60.1% | 10,800 | -56.7% | 0.00% | -66.7% |
| Q3 2014 | $343,000 | -85.3% | 24,969 | -81.7% | 0.00% | -88.5% |
| Q1 2014 | $2,326,000 | – | 136,516 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |